The presence of pharmaceuticals in the effluents from municipal sewage treatment plants (STPs) has been reported to be the major source of these biologically active compounds in the aquatic environment. Scarce indications are found in the literature about the fate of pharmaceuticals in STPs, their environmental persistence and ecotoxicity, complementary treatments to integrate with conventional biological processes.
The present project will contribute to fill this gap of knowledge by
1) assessing the presence of widely used pharmaceuticals in municipal wastewaters and their fate in treatment processes
2) assessing their refractoriness to undergo naturally occurring abiotic and biotic transformations
3) assessing the toxic effects these compounds may exert on living organisms such as algae, invertebrates and fish
4) investigating complementary biological and chemical treatments for the reduction of their concentrations in STP plants.
Funding SchemeCSC - Cost-sharing contracts